Gregory Albers

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Warfarin prevails for stroke prevention in atrial fibrillation--even in octogenarians
    Gregory W Albers
    Lancet Neurol 6:844-6. 2007
  2. doi request reprint Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Gregory W Albers
    Stanford University Medical Center, Stanford Stroke Center, 701 Welch Road, Palo Alto, CA 94304 1705, USA
    Chest 133:630S-669S. 2008
  3. pmc Yield of combined perfusion and diffusion MR imaging in hemispheric TIA
    M Mlynash
    Department of Neurology and Neurological Sciences, Stanford Stroke Center, 701 Welch Road, Suite B325, Palo Alto, CA 94304, USA
    Neurology 72:1127-33. 2009
  4. ncbi request reprint Can the ESPRIT results end the antiplatelet battle between neurologists and cardiologists?
    Gregory W Albers
    Neurology and Neurological Sciences, Stanford University, 701 Welch Road 325, Stanford, CA 94305, USA
    Nat Clin Pract Cardiovasc Med 4:118-9. 2007
  5. ncbi request reprint Intravenous alteplase for ischaemic stroke
    Gregory W Albers
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
    Lancet 369:249-50. 2007
  6. doi request reprint Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies
    Gregory W Albers
    Stanford Stroke Center, 780 Welch Road, Suite 205, Palo Alto, CA 94304, USA
    Stroke 42:2645-50. 2011
  7. ncbi request reprint Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
    Gregory W Albers
    Department of Neurology and Neurological Sciences and the Stanford Stroke Center, Stanford University Medical Center, Stanford, CA 94304, USA
    Ann Neurol 60:508-17. 2006
  8. ncbi request reprint Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging
    Oliver C Singer
    Klinik fur Neurologie, Universitatsklinik, Johann Wolfgang von Goethe Universit├Ąt, Frankfurt, Germany
    Ann Neurol 63:52-60. 2008
  9. ncbi request reprint Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients
    Jens Fiehler
    Department of Neuroradiology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    Stroke 38:2738-44. 2007
  10. pmc Neurological picture. Acute strokes in the setting of a persistent primitive trigeminal artery
    Neil E Schwartz
    Stanford Stroke Center, Stanford University Medical Center, 701 Welch Road, Suite B325, Palo Alto, CA 94304 5749, USA
    J Neurol Neurosurg Psychiatry 78:745. 2007

Detail Information

Publications55

  1. ncbi request reprint Warfarin prevails for stroke prevention in atrial fibrillation--even in octogenarians
    Gregory W Albers
    Lancet Neurol 6:844-6. 2007
  2. doi request reprint Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Gregory W Albers
    Stanford University Medical Center, Stanford Stroke Center, 701 Welch Road, Palo Alto, CA 94304 1705, USA
    Chest 133:630S-669S. 2008
    ..5; range, 2.0 to 3.0) [Grade 1A]. In patients with venous sinus thrombosis, we recommend unfractionated heparin (Grade 1B) or low-molecular-weight heparin (Grade 1B) over no anticoagulant therapy during the acute phase...
  3. pmc Yield of combined perfusion and diffusion MR imaging in hemispheric TIA
    M Mlynash
    Department of Neurology and Neurological Sciences, Stanford Stroke Center, 701 Welch Road, Suite B325, Palo Alto, CA 94304, USA
    Neurology 72:1127-33. 2009
    ..Diffusion-weighted MRI (DWI) demonstrates acute ischemic lesions in approximately 30% of TIA patients; the yield of perfusion-weighted MRI (PWI) is unclear...
  4. ncbi request reprint Can the ESPRIT results end the antiplatelet battle between neurologists and cardiologists?
    Gregory W Albers
    Neurology and Neurological Sciences, Stanford University, 701 Welch Road 325, Stanford, CA 94305, USA
    Nat Clin Pract Cardiovasc Med 4:118-9. 2007
  5. ncbi request reprint Intravenous alteplase for ischaemic stroke
    Gregory W Albers
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
    Lancet 369:249-50. 2007
  6. doi request reprint Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies
    Gregory W Albers
    Stanford Stroke Center, 780 Welch Road, Suite 205, Palo Alto, CA 94304, USA
    Stroke 42:2645-50. 2011
    ....
  7. ncbi request reprint Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
    Gregory W Albers
    Department of Neurology and Neurological Sciences and the Stanford Stroke Center, Stanford University Medical Center, Stanford, CA 94304, USA
    Ann Neurol 60:508-17. 2006
    ..To determine whether prespecified baseline magnetic resonance imaging (MRI) profiles can identify stroke patients who have a robust clinical response after early reperfusion when treated 3 to 6 hours after symptom onset...
  8. ncbi request reprint Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging
    Oliver C Singer
    Klinik fur Neurologie, Universitatsklinik, Johann Wolfgang von Goethe Universit├Ąt, Frankfurt, Germany
    Ann Neurol 63:52-60. 2008
    ..Here, we investigated the relation between pretreatment DWI lesion size and the risk for sICH after thrombolysis...
  9. ncbi request reprint Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients
    Jens Fiehler
    Department of Neuroradiology, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    Stroke 38:2738-44. 2007
    ..Because of this concern, some centers withhold potentially beneficial thrombolytic therapy from these patients...
  10. pmc Neurological picture. Acute strokes in the setting of a persistent primitive trigeminal artery
    Neil E Schwartz
    Stanford Stroke Center, Stanford University Medical Center, 701 Welch Road, Suite B325, Palo Alto, CA 94304 5749, USA
    J Neurol Neurosurg Psychiatry 78:745. 2007
  11. pmc Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE)
    Jean Marc Olivot
    Department of Neurology and Neurological Sciences and the Stanford Stroke Center, Stanford University Medical Center, 701 Welch Road, Suite 325, Palo Alto, CA 94304, USA
    Stroke 39:2257-63. 2008
    ..The purpose of this study was to determine the relationships between ischemic lesion growth, recanalization, and clinical response in stroke patients with and without a perfusion/diffusion mismatch...
  12. ncbi request reprint Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke
    Maarten G Lansberg
    Stanford University, Stanford Stroke Center, Palo Alto, California 94304, USA
    Stroke 38:2275-8. 2007
    ..MRI-based variables have generally not been included in predictive models, and little is known about the influence of reperfusion on SICH risk...
  13. ncbi request reprint Transient isolated vertigo secondary to an acute stroke of the cerebellar nodulus
    Neil E Schwartz
    Stanford Stroke Center, Stanford University Medical Center, 701 Welch Rd, Suite B325, Palo Alto, CA 94304 5749, USA
    Arch Neurol 64:897-8. 2007
  14. ncbi request reprint Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors
    Maarten G Lansberg
    Stanford University, Stanford Stroke Center, Palo Alto, CA 94304, USA
    Cerebrovasc Dis 24:1-10. 2007
    ....
  15. doi request reprint Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients
    Wataru Kakuda
    Department of Rehabilitation Medicine, Jikei University School of Medicine, Minato ku, Tokyo, Japan
    J Cereb Blood Flow Metab 28:887-91. 2008
    ..Defining mismatch with a larger PWI/DWI ratio may provide greater power for detecting beneficial effects of reperfusion...
  16. ncbi request reprint Use of antiplatelet agents to prevent stroke: what is the role for combinations of medications?
    Neil E Schwartz
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University, 701 Welch Road, B325, Palo Alto, CA 94304, USA
    Curr Neurol Neurosci Rep 8:29-34. 2008
    ..The combination of aspirin and extended-release dipyridamole has demonstrated superiority over aspirin in two large secondary stroke prevention trials...
  17. pmc Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study
    Michael P Marks
    Department of Radiology, Neurosurgery, Stanford University Medical Center, Stanford, CA 94305 5105, USA
    Radiology 249:614-23. 2008
    ..To study magnetic resonance (MR) angiography findings in patients with acute stroke treated with intravenous tissue plasminogen activator (tPA) in relationship to perfusion- and diffusion-weighted imaging changes and clinical outcome...
  18. pmc Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
    Ralph L Sacco
    Miller School of Medicine, University of Miami, Miami, USA
    N Engl J Med 359:1238-51. 2008
    ..Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens--aspirin plus extended-release dipyridamole (ASA-ERDP) versus clopidogrel...
  19. doi request reprint The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion
    Maarten G Lansberg
    Stanford Stroke Center, 701 Welch Road, Suite B325, Palo Alto, CA 94304 9705, USA
    Stroke 39:2491-6. 2008
    ....
  20. doi request reprint Optimal outcome measures for detecting clinical benefits of early reperfusion: insights from the DEFUSE Study
    Wataru Kakuda
    Department of Rehabilitation Medicine, Jikei University School of Medicine, Tokyo, Japan
    J Stroke Cerebrovasc Dis 17:235-40. 2008
    ..There is no consensus regarding which clinical outcome scales are the most sensitive indicators of early reperfusion in patients with acute stroke...
  21. ncbi request reprint Effect of ximelagatran and warfarin on stroke subtypes in atrial fibrillation
    Jeanne S Teitelbaum
    Department of Neurology, Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada
    Can J Neurol Sci 35:160-5. 2008
    ..We assessed any differential effect of warfarin versus ximelagatran on the risk and outcome of cardioembolic and noncardioembolic stroke...
  22. doi request reprint Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Daniel E Singer
    Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    Chest 133:546S-592S. 2008
    ..However, in patients without contraindications to anticoagulation, we suggest beginning IV heparin or LMWH at presentation (Grade 2C)...
  23. doi request reprint Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Jack Hirsh
    Hamilton Civic Hospitals, Hamilton, Ontario, Canada
    Chest 133:110S-112S. 2008
    ....
  24. doi request reprint Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Jack Hirsh
    Hamilton Civic Hospitals, Hamilton, Ontario, Canada
    Chest 133:71S-109S. 2008
  25. doi request reprint Acute stroke imaging research roadmap
    Max Wintermark
    University of California, San Francisco, Department of Radiology, Neuroradiology Section, 505 Parnassus Avenue, Box 0628, San Francisco, CA 94143 0628, USA
    Stroke 39:1621-8. 2008
    ..The present article summarizes these recommendations and examines practical steps to achieve them...
  26. ncbi request reprint Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE
    Maarten G Lansberg
    Stanford Stroke Center, Stanford University Medical Center, Palo Alto, CA 94304, USA
    Stroke 38:1826-30. 2007
    ..The clinical-diffusion mismatch (CDM) model is an alternative method that is technically less challenging because it does not require perfusion-weighted imaging. This study is an evaluation of these 2 models in the DEFUSE dataset...
  27. ncbi request reprint Clinical multishot DW-EPI through parallel imaging with considerations of susceptibility, motion, and noise
    Stefan Skare
    Lucas MRS I Center, Department of Radiology, Stanford University, California 94305, USA
    Magn Reson Med 57:881-90. 2007
    ..The image quality improvements without SNR efficiency loss, together with motion tolerance, make the GRAPPA-driven DW-EPI sequence clinically attractive...
  28. ncbi request reprint The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison
    David G Sherman
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Lancet 369:1347-55. 2007
    ..We aimed to compare the efficacy and safety of enoxaparin with that of unfractionated heparin for patients with stroke...
  29. ncbi request reprint ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke
    Gregory W Albers
    Stanford University School of Medicine, Stanford, Calif, USA
    Stroke 33:493-5. 2002
    ..Only a single study has demonstrated beneficial effects of intravenous tissue plasminogen activator (tPA) in stroke patients...
  30. ncbi request reprint Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial
    Gregory W Albers
    Stanford Stroke Center, Palo Alto, Calif, USA
    JAMA 293:690-8. 2005
    ..In patients with nonvalvular atrial fibrillation, warfarin prevents ischemic stroke, but dose adjustment, coagulation monitoring, and bleeding limit its use...
  31. ncbi request reprint Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials
    Gregory W Albers
    Stanford Stroke Center, Palo Alto, California, USA
    Am J Manag Care 10:S462-9; discussion S469-73. 2004
    ..This oral direct thrombin inhibitor is a potentially promising treatment option for the prevention of thromboembolism...
  32. ncbi request reprint Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size
    Dong Gyu Na
    Department of Radiology, Stanford University Medical Center, Stanford, CA 94305 5105, USA
    AJNR Am J Neuroradiol 25:1331-6. 2004
    ..This study was performed to determine whether pixel-based apparent diffusion coefficient (ADC) and signal intensity ratio are helpful diffusion-weighted (DW) imaging metrics to predict tissue at risk for infarction...
  33. ncbi request reprint Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Gregory W Albers
    Stanford University Medical Center, Stanford Stroke Center, 701 Welch Rd, Building B, Suite 325, Palo Alto, CA 94304 1705, USA
    Chest 126:483S-512S. 2004
    ..5; range, 2.0 to 3.0) [Grade 1A]. In patients with venous sinus thrombosis, we recommend unfractionated heparin (Grade 1B) or low molecular weight heparin (Grade 1B) over no anticoagulant therapy during the acute phase...
  34. ncbi request reprint Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Daniel E Singer
    Clinical Epidemiology Unit, S50 9, Massachusetts General Hospital, Boston, MA 02114, USA
    Chest 126:429S-456S. 2004
    ..However, in patients without contraindications to anticoagulation, we suggest beginning IV heparin or low molecular weight heparin at presentation (Grade 2C)...
  35. ncbi request reprint A review of published TIA treatment recommendations
    Gregory W Albers
    Stanford Stroke Center, Stanford University, Palo Alto, CA, USA
    Neurology 62:S26-8. 2004
  36. ncbi request reprint Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
    Stanley G Rockson
    Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    J Am Coll Cardiol 43:929-35. 2004
    ....
  37. ncbi request reprint Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging
    Vincent N Thijs
    Department of Neurology, UZ Gasthuisberg, Herestraat 49, B 3000 Leuven, Belgium
    Stroke 35:94-8. 2004
    ..We studied the effect of varying the location of measurement of AIF on the volume of hypoperfusion. We compared the volumes of hypoperfusion obtained with different AIFs with the final ischemic lesion volume...
  38. ncbi request reprint Patient safety in trials of therapy for acute ischemic stroke
    Larry B Goldstein
    JAMA 287:987. 2002
  39. ncbi request reprint Oral antiplatelet therapy
    Richard A Bernstein
    JAMA 293:793-4; author reply 794-5. 2005
  40. ncbi request reprint Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials
    Paul T Akins
    Mercy Stroke Center, Sacramento, CA, USA
    Stroke 38:874-80. 2007
    ..Patients with nonvalvular atrial fibrillation and prior stroke or transient ischemic attack (TIA) are at high risk for recurrent stroke. We investigated whether ximelagatran was noninferior to warfarin in patients with prior stroke or TIA...
  41. ncbi request reprint Perfusion mapping with multiecho multishot parallel imaging EPI
    Rexford D Newbould
    Lucas MRS I Center, Department of Radiology, Stanford University, Stanford, California 94305 5488, USA
    Magn Reson Med 58:70-81. 2007
    ..The use of this method for DSC addresses the problem of signal saturation and T(1) contamination while it improves image quality, and is a logical step toward better quantitative MR PWI...
  42. ncbi request reprint Identifying systematic errors in quantitative dynamic-susceptibility contrast perfusion imaging by high-resolution multi-echo parallel EPI
    Thies H Jochimsen
    Max Planck Institute for Human Cognitive and Brain Sciences, Stephanstr 1a, D 04103 Leipzig, Germany
    NMR Biomed 20:429-38. 2007
    ..Therefore, DSC-MRI requires knowledge of the exact dependency of transverse relaxation rate upon tracer concentration in order to calculate truly quantitative perfusion maps...
  43. ncbi request reprint Acute cerebrovascular syndrome: time for new terminology for acute brain ischemia
    Gregory W Albers
    Nat Clin Pract Cardiovasc Med 3:521. 2006
  44. ncbi request reprint Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V
    Harvey D White
    Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 1030, New Zealand
    Arch Intern Med 167:239-45. 2007
    ..Target INRs are frequently not achieved, and the risk of death, bleeding, myocardial infarction (MI), and stroke or systemic embolism event (SEE) may be related to INR control...
  45. ncbi request reprint Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset
    Anthony J Furlan
    Department of Neurology, The Cleveland Clinic, Cleveland, OH 44195, USA
    Stroke 37:1227-31. 2006
    ..This study evaluated safety and efficacy of intravenous (IV) desmoteplase in patients with perfusion/diffusion mismatch on MRI 3 to 9 hours after onset of acute ischemic stroke...
  46. ncbi request reprint Mechanical thrombectomy following intravenous thrombolysis in the treatment of acute stroke
    Maarten G Lansberg
    Department of Neurology, Stanford University Medical Center, Stanford, Calif 94305, USA
    Arch Neurol 62:1763-5. 2005
    ..Treatment with intravenous thrombolytics followed by mechanical thrombectomy is a novel approach that may increase recanalization rates without compromising time to initiation of treatment...
  47. ncbi request reprint Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable
    Marc Fisher
    UMass Memorial Healthcare Center, 119 Belmont St, Worcester, MA 01605, USA
    Stroke 36:1808-13. 2005
    ..A fourth (STAIR-IV) was held to discuss relevant issues related to acute stroke drug development and regulatory approval...
  48. ncbi request reprint Clinical and radiological correlates of reduced cerebral blood flow measured using magnetic resonance imaging
    Vincent N Thijs
    Department of Neurology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Herestraat 49, 3000 Leuven, Belgium
    Arch Neurol 59:233-8. 2002
    ..Reduced apparent diffusion coefficient (ADC) values of brain tissue are associated with reductions in regional CBF in animal stroke models...
  49. pmc Telmisartan to prevent recurrent stroke and cardiovascular events
    Salim Yusuf
    Population Health Research Institute, McMaster University, Hamilton, ON, Canada
    N Engl J Med 359:1225-37. 2008
    ..We evaluated the effects of therapy with an angiotensin-receptor blocker, telmisartan, initiated early after a stroke...
  50. ncbi request reprint Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up
    Michael P Marks
    Department of Radiology, Stanford University Medical Center, Stanford, CA 94305, USA
    AJNR Am J Neuroradiol 26:525-30. 2005
    ..This study was undertaken to assess the efficacy and long-term clinical outcome of angioplasty without stent placement for patients with symptomatic intracranial stenosis...
  51. ncbi request reprint Safety and tolerability of arundic acid in acute ischemic stroke
    L Creed Pettigrew
    Stroke Program, Sanders Brown Center on Aging, and Department of Neurology, 101 Sanders Brown Building, University of Kentucky Medical Center, Lexington, KY 40536 0230, USA
    J Neurol Sci 251:50-6. 2006
    ..023 vs. placebo), 7 (p=0.002), 10 (p=0.003), and 40 (p=0.018). A dose of 8 mg/kg/h AA produced a favorable trend in reduction of NIHSS that should be confirmed in a future clinical trial...
  52. ncbi request reprint Trials and tribulations of noninferiority: the ximelagatran experience
    Gregory W Albers
    J Am Coll Cardiol 48:1058; author reply 1059. 2006
  53. ncbi request reprint Optimizing oral anticoagulation in managed care
    J Jaime Caro
    Caro Research, Concord, Massachusetts, USA
    Am J Manag Care 10:S474-7. 2004
  54. pmc Acute stroke imaging research roadmap
    Max Wintermark
    Department of Radiology, University of California, San Francisco, CA 94143 0628, USA
    AJNR Am J Neuroradiol 29:e23-30. 2008
    ..The present article summarizes these recommendations and examines practical steps to achieve them...

Research Grants9

  1. NEW MRI TECHNIQUES PRIOR TO T-PA THERAPY AFTER STROKE
    Gregory Albers; Fiscal Year: 2003
    ....
  2. New MRI techniques for cerebrovascular diseases
    Gregory Albers; Fiscal Year: 2007
    ..This K24 research program will expand Dr. Albers' skills as a clinical investigator and allow him to become a more effective mentor. ..
  3. Diffusion weighted imaging Evaluation For Understanding Stroke Evolution2:DEFUSE
    Gregory W Albers; Fiscal Year: 2010
    ..These findings will eventually lead to effective therapies for a large population of stroke patients who are currently ineligible for treatment and substantially reduce stroke-related disability. ..